Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now later-stage tilt small index

Insomnia Disorder: later-stage trial registry

4 of 9 indexed Insomnia Disorder trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 4 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Insomnia Disorder: 9 US clinical trials tracked, 4 recruiting.

Insomnia Disorder is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Idorsia Pharmaceuticals, running 3 of these trials.

Enrollment posture brief

Registry condition insomnia-disorder

OPEN 4 | RECR 44% | LATE 3 | EARLY 0 | RANK #1916 | SPON 3

Nearest open-share peer: Acute Ischemic Stroke (44% recruiting · 27 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Insomnia Disorder (this)44%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Insomnia Disorder

Insomnia Disorder lists 4 open slots (44% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Insomnia Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Insomnia Disorder is recruiting below its size-band peers.

    4 of 9 indexed trials (44.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Insomnia Disorder research.

    Idorsia Pharmaceuticals accounts for 3 of 9 trials (33.3%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Insomnia Disorder enrolment sits around 60 participants.

    Median target enrolment is 60 among the 9 trials that report a genuine target (sentinel values excluded). 5 of those (55.6%) plan for fewer than 100 participants.

  4. Insomnia Disorder research is mostly interventional.

    8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 32Phase 41

Open and recent trials

9 total, page 1 of 1

Phase Distribution

PhaseTrial count
Phase 3 2
Phase 4 1

Named interventions

Most-linked intervention names on Insomnia Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Passive Body Heating (PBH) Device
2 trials
Daridorexant Drug
2 trials
Placebo Drug
2 trials
Daridorexant 25 mg Drug
1 trials
education and coaching on developing healthy nighttime sleep and daytime activity behaviors Behavioral
1 trials
Non-orexin receptor antagonist insomnia medication Drug
1 trials
Daridorexant 50 mg Drug
1 trials
CBTi: Sleep Compression Core Behavioral
1 trials

US sites by state

Facility locations filed on Insomnia Disorder trials. A trial with sites in several states counts in each.

California 4 trials
North Carolina 3 trials
Florida 3 trials
Texas 1 trials
Nevada 1 trials
Nebraska 1 trials
Maryland 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Insomnia Disorder page

9 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Insomnia Disorder condition card totals 9 registered trials; most-linked intervention Passive Body Heating (PBH); top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.